Search for:
Antitrust / Competition

Global: Webinar – The ESG imperative – rethinking healthcare and life science supply chains

By , , , and 1 Min Read

Beyond resilience, the supply chains of the future are expected to be sustainable, embracing ESG principles. In the seventh webinar of our Supply Chain Series, our panel of experts will discuss the emerging and anticipated business issues, practical applications and legal considerations that companies need to consider, as they:

  • Integrate corporate governance into the value chain
  • Look at access to medicines and medical devices in a post-pandemic era
  • Explore sustainable alternatives such as corporate power purchase agreements
  • Navigate the growing convergence of antitrust and ESG

Click here to register

This one-hour Zoom webinar is free to attend and eligible for CLE and CPD credits. More information and joining details will be provided upon registration.

Categories:
Author

Alvaro Gutierrez is a partner in Estudio Echecopar. He acted as secretary of the Commission of the Andean Community at the General Secretariat of the Andean Community and the Cartagena Agreement Board. Alvaro was part of the Andean Community's team that negotiated an association agreement with the EU's Intellectual Property Chapter and for the Chapter on Intellectual Property in ALCA (America's Free Trade). He was adviser to the vice minister on foreign trade in negotiations for the free trade agreement with the US. Alvaro is also a former vice president of the Peruvian Copyright Office.
Estudio Echecopar is a member firm of Baker & McKenzie International, a Swiss Verein

Author

Jo Hewitt is a partner in the Corporate Department of Baker McKenzie London, and advises clients on a wide range of corporate law matters.

Author

Dr. Lopez Silva is the head of Healthcare & Life Sciences Industry Group in Mexico, as well as a member of the Steering Committee of the North American and Latin America Healthcare Group. He has more than 17 years of experience in regulation of life sciences, pharmaceutical law and biotechnology matters, having worked in the private and public sectors and at the national and international level. For several consecutive years, Dr. Lopez Silva has led the rankings for Life Sciences both nationally (Chambers Latin America) and internationally (Chambers Global).

Author

Hari is a principal in the Competition & Antitrust Practice Group at Baker McKenzie Wong & Leow. His practice covers competition law and regulation-related advisory work in Singapore and the Southeast Asia region. Hari was the Director of the Enforcement Division at the Competition and Consumer Commission of Singapore (CCCS), where he supervised the CCCS’s Intelligence Unit and IT Forensics Taskforce, in addition to the supervision of case teams on various investigations, mergers and notifications. He was also responsible for managing leniency applications made to the CCCS, overseeing the secret complainant and reward schemes, planning and executing dawn raids, and recording investigative statements of persons under investigations. Hari led teams involved in defending appeals brought against the CCCS’s decisions before the Competition Appeals Board. Prior to joining the Baker McKenzie Wong & Leow, Hari completed stints in private practice and as a Justices' Law Clerk with the Singapore Legal Service. Hari is recognised as one of "Who's Who Legal: Competition Future Leaders - Partners" in the 2020 Who's Who Legal Competition law survey conducted in conjunction with Global Competition Review.

Author

Graham Richmond is a Senior Associate in Baker & McKenzie's Global Energy, Mining and Infrastructure Industry Group and Projects Practice Group, based in London. Graham has more than 10 years' experience working on construction, project development and finance and related commercial arrangements and secondary transactions across the EMEA region and globally.

Related Posts

Write A Comment